- Report
- April 2024
- 193 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- May 2023
- 144 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- February 2024
- 119 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2022
- 81 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- November 2021
- 1032 Pages
Global
From €4834EUR$5,000USD£4,152GBP
Functional biomarkers are a type of biomarker used to measure the activity of a biological process or pathway. They are used to assess the efficacy of a drug or therapy, as well as to diagnose and monitor diseases. Functional biomarkers are typically measured through gene expression, protein expression, or metabolite levels. They are often used in combination with other biomarkers to provide a more comprehensive picture of a patient's health.
Functional biomarkers are becoming increasingly important in the field of personalized medicine, as they can provide a more detailed understanding of a patient's health and response to treatment. They are also being used to develop new treatments and therapies, as well as to monitor the progression of diseases.
Some companies in the functional biomarker market include Illumina, Thermo Fisher Scientific, Qiagen, and Roche. Show Less Read more